Collaboration with Dr Peter Gasser, Dr Thorsten Passie and MAPS

In 2008, we co-sponsored this MAPS-led trial of LSD-assisted psychotherapy for end-of-life anxiety. This was the first LSD study approved by the U.S. Food and Drug Administration in 40 years, and the results demonstrated that LSD paired with psychotherapy could alleviate ‘existential stress’ associated with terminal illness, putting the drug’s medical potential back in the spotlight for the first time since the 1960s.